Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study

Autor: Kim, Dong-Wan, Chul Cho, Byoung, Pachipala, Krishna, Kim, Sang-We, Wang, Chih-Liang, Chang, Gee-Chen, Ahn, Myung-Ju, Alvarez, Rosa, Chiu, Chao-Hua, Trigo, José, Estival, Anna, Karam, Sana D., O'Brien, Cathy, Gowda, Hema, Jiang, Haiyi, Bauman, Julie E.
Zdroj: In Lung Cancer April 2024 190
Databáze: ScienceDirect
Externí odkaz: